Lipella Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Lipella Pharmaceuticals has a total shareholder equity of $3.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.6M and $432.7K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$3.29m |
Equity | US$3.14m |
Total liabilities | US$432.73k |
Total assets | US$3.58m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LIPO's short term assets ($3.4M) exceed its short term liabilities ($385.4K).
Long Term Liabilities: LIPO's short term assets ($3.4M) exceed its long term liabilities ($47.4K).
Debt to Equity History and Analysis
Debt Level: LIPO is debt free.
Reducing Debt: LIPO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LIPO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LIPO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 46.8% each year